Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin antigen-presenting cells (APCs) are a heterogeneous population of immune cells, including epidermal Langerhans cells and dermal dendritic cells, that serve as the primary sentinels of the cutaneous immune system. Their main biological role is to capture antigens from the environment or damaged tissue, process them, and migrate to skin-draining lymph nodes to present these antigens to naive T cells, thereby initiating adaptive immune responses or maintaining self-tolerance (Nestle et al., 2009, Nature Reviews Immunology). In various pathologies, such as psoriasis or atopic dermatitis, these cells can become overactive, driving chronic inflammation through the secretion of pro-inflammatory cytokines and the activation of pathogenic T-cell subsets (Kissenpfennig & Guilliams, 2010, Expert Reviews in Molecular Medicine). Conversely, in the context of skin cancer, their function may be suppressed, allowing for immune evasion by the tumor. Therapeutic interventions targeting skin APCs include topical corticosteroids and calcineurin inhibitors to reduce their activation in inflammatory diseases, as well as the use of adjuvants in intradermal vaccines to enhance their ability to stimulate protective immunity (Kim et al., 2012, Current Topics in Microbiology and Immunology). Because "Skin antigen-presenting cells" refers to a broad cell population rather than a single protein, it is considered a cellular target rather than a specific molecular target.
Modulation of antigen uptake, processing, and presentation; inhibition of pro-inflammatory cytokine production; and regulation of immune cell migration to regional lymph nodes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin antigen-presenting cell (Skin APC) (Skin APC).